BIRC5 and prostate cancer: Khan et al. [87] showed that Survivin, an inhibitor of apoptosis member, could bedetected in plasma-derived EVs from both prostate cancer patients and healthy subjects;however, the relative amount of EV Survivin was remarkably higher in the plasma ofprostate cancer patients.